FINWIRES · TerminalLIVE
FINWIRES

Eli Lilly Strong Q1 Results Show Stable Pricing, Foundayo Volatility Remains, RBC Says

By

Eli Lilly (LLY) reported strong Q1 results driven by GLP-1 drugs, with fundamentals remaining solid and pricing stabilizing, RBC Capital Markets said, while warning that volatility around its new drug Foundayo remains.

The company raised its full-year 2026 adjusted EPS outlook to $35.50 to $37 per share from $33.50 to $35 and reported Q1 results above expectations. RBC also lifted its full-year 2026 EPS forecast to $36.24 from $33.59 and increased its revenue estimate to $85.1 billion from $83.2 billion.

Foundayo has reached about 20,000 prescriptions so far. The investment firm said it is still too early to assess demand and expects data to remain volatile as the launch develops.

The brokerage said it was "encouraging" that Mounjaro prescriptions in India rose about 10% even after the entry of cheaper generics. It also noted that pricing trends have stabilized, with management reaffirming low-to-mid teens year-on-year declines.

RBC maintained its outperform rating and $1,250 price target, saying the stock remains undervalued given long-term growth prospects.

Price: $962.47, Change: $+27.87, Percent Change: +2.98%

Related Articles

Wire

Tanger Q1 Core FFO, Revenue Rise; 2026 Guidance Increased

Tanger (SKT) reported Q1 core funds from operations late Thursday of $0.59 per diluted share, up from $0.53 a year earlier.Analysts polled by FactSet expected $0.58.Revenue in the three months ended March 31 rose to $150.4 million from $135.4 million a year earlier.Analysts surveyed by FactSet expected $142.9 million.The company raised 2026 FFO guidance to $2.42 to $2.50 per diluted share from $2.41 to $2.49.Analysts polled by FactSet expect $2.47.Tanger shares fell 2.3% in after-hours trading.

$SKT
Wire

Alignment Healthcare Swings to Q1 Profit, Revenue Rises; Shares Fall After Hours

Alignment Healthcare (ALHC) reported Q1 earnings late Thursday of $0.05 per diluted share, compared with the loss of $0.05 a year earlier.Analysts polled by FactSet expected earnings of $0.01.Revenue in the three months ended March 31 rose to $1.24 billion from $926.9 million a year ago.Analysts surveyed by FactSet expected $1.22 billion.The company expects revenue of $1.3 billion to $1.32 billion in Q2 and $5.16 billion to $5.21 billion in the full year.Analysts project $1.31 billion in Q2 and $5.17 billion in 2026.Alignment Healthcare shares fell 10% in after-hours trading.

$ALHC
Wire

GoDaddy Q1 Earnings, Revenue Rise; Shares Gain After Hours

GoDaddy (GDDY) reported Q1 earnings late Thursday of $1.60 per diluted share, up from $1.51 a year earlier.Analysts polled by FactSet expected $1.52.Revenue in the three months ended March 31 rose to $1.27 billion from $1.19 billion a year earlier.Analysts surveyed by FactSet expected $1.26 billion.The company expects Q2 revenue of $1.29 billion to $1.31 billion. Analysts surveyed by FactSet expect $1.29 billion.GoDaddy reaffirmed 2026 revenue guidance of $5.2 billion to $5.28 billion. Analysts surveyed by FactSet expect $5.24 billion.In Q1, the company repurchased 3 million shares for $279.7 million.GoDaddy shares rose 4.2% in after-hours trading.

$GDDY